International Patent: CROSSLINKED HYALURONIC ACID POWDER HAVING IMPROVED WATER RE-ABSORPTION RATE AND PREPARATION METHOD THEREFOR

GENEVA, Oct. 30 -- USCAREPHARM CO.,LTD filed a patent application (KR2025/019086) for “CROSSLINKED HYALURONIC ACID POWDER HAVING IMPROVED WATER RE-ABSORPTION RATE AND PREPARATION METHOD THEREFOR”. With publication no. WO/2026/225701, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C08B 37/08

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....